Treatment Details
  • Treatment Details
  • Directions
  • Side Effects
  • Important Information
  • What are Atovaquone/Proguanil Tablets?
    Atovaquone/Proguanil Tablets are a generic prescription medication used to prevent malaria. They contain the same active ingredients as Malarone—atovaquone and proguanil—offering the same level of protection against malaria. This generic version is a cost-effective option for travelers heading to areas where malaria is prevalent.

    How do Atovaquone/Proguanil Tablets work?
    These tablets work by combining the effects of atovaquone and proguanil to disrupt the life cycle of the malaria parasite. Atovaquone inhibits the parasite's ability to produce energy, while proguanil interferes with its reproduction, effectively preventing the spread of the parasite in the body.

    Additional Information

    Onset of Action: Start 1-2 days before entering the malaria risk area.
    Duration of Effect: Continue taking daily while in the area and for 7 days after leaving.

  • How to Use Atovaquone/Proguanil Tablets:

    • Take one tablet daily with food or a milky drink.
    • Begin 1-2 days before entering the malaria area, continue daily during the stay, and for 7 days after leaving.
    • Do not exceed the recommended dosage.

    Important Information:

    • Not recommended for individuals with severe kidney disease.
    • Consult a doctor before use if pregnant, breastfeeding, or taking other medications.
    • Should be used alongside other malaria prevention methods such as mosquito repellent.
       
  • Common side effects may include:

    • Nausea
    • Vomiting
    • Abdominal pain
    • Headache
    • Dizziness

    In rare cases, serious side effects like allergic reactions or severe skin rashes may occur. Discontinue use and seek medical advice if severe symptoms develop.

  • Before taking Atovaquone/Proguanil Tablets, please read the Patient Information Leaflet (PIL). It provides essential details on dosage, side effects, and safe use.

    For complete information, refer to the Atovaquone/Proguanil Patient Information Leaflet (PIL).

Frequently asked questions
  • What conditions do Atovaquone/Proguanil Tablets help prevent?

    Atovaquone/Proguanil Tablets are specifically formulated to prevent malaria, a serious and potentially deadly disease spread by mosquitoes in high-risk tropical and subtropical regions. This generic alternative to Malarone offers the same dual-action protection by combining atovaquone and proguanil, ensuring comprehensive malaria prevention for travelers.

  • How often should I take Atovaquone/Proguanil Tablets?

    You should take one Atovaquone/Proguanil tablet daily, starting 1-2 days before entering a malaria-endemic area. Continue taking the medication throughout your stay and for 7 days after leaving the area. Consistent daily dosing is crucial for maintaining effective malaria prevention during your travels.

  • Are Atovaquone/Proguanil Tablets safe for children?

    Atovaquone/Proguanil Tablets are safe for children when dosed correctly based on their weight. It’s essential to consult a healthcare professional to determine the appropriate dosage for children. This generic malaria prevention option offers an affordable and effective solution for families traveling to malaria-prone regions.

  • Can I take Atovaquone/Proguanil Tablets with other medications?

    Before taking Atovaquone/Proguanil, it’s important to consult a healthcare professional, especially if you’re taking other medications. Certain drugs may interact with Atovaquone/Proguanil, potentially affecting its efficacy in preventing malaria or increasing the risk of side effects. Proper medical guidance ensures safe and effective use.

  • What should I do if I experience side effects from Atovaquone/Proguanil Tablets?

    Common side effects of Atovaquone/Proguanil include nausea, headache, and stomach upset. If you experience mild side effects, continue taking the medication and inform your doctor. However, if you develop severe symptoms such as allergic reactions or significant skin rashes, discontinue use and seek immediate medical attention to ensure your safety while preventing malaria.

Copyright 2025